Cincinnati Eye Institute

Futó vizsgálatok

• Toboroz

  A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions

  NCT07734064· 1. fázis· Forrás

• Toboroz

  A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults

  NCT07425574· Forrás

• Toboroz

  Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)

  NCT07185256· 1/2. fázis· Forrás

• Fut, nem toboroz

  A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa

  NCT07174726· 2. fázis· Forrás

• Toboroz

  Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

  NCT07064759· 3. fázis· Forrás

• Fut, nem toboroz

  Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration

  NCT06495918· 3. fázis· Forrás

• Toboroz

  A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

  NCT06541704· 3. fázis· Forrás

• Toboroz

  A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  NCT06635148· 2/3. fázis· Forrás

• Fut, nem toboroz

  A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)

  NCT06491914· 3. fázis· Forrás

• Toboroz

  Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)

  NCT06445322· Forrás

• Fut, nem toboroz

  Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)

  NCT06467344· 1/2. fázis· Forrás

• Fut, nem toboroz

  A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP

  NCT04850118· 2/3. fázis· Forrás

• Meghívásos bevonás

  A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN)

  NCT06275620· 2. fázis· Forrás

• Fut, nem toboroz

  NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration

  NCT05984927· 1/2. fázis· Forrás

• Toboroz

  A Registry Study to Assess Photobiomodulation in Dry Age-Related Macular Degeneration (GLOBALIGHT)

  NCT06351605· Forrás

• Meghívásos bevonás

  ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study

  NCT05481827· 2. fázis· Forrás

• Fut, nem toboroz

  A Study Comparing Two Doses of AGTC-501 in Male Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (SKYLINE)

  NCT06333249· 2. fázis· Forrás

• Toboroz

  Extension Study for the Port Delivery System With Ranibizumab (Portal)

  NCT03683251· 3. fázis· Forrás

• Fut, nem toboroz

  Safety and Efficacy of rAAV2tYF-GRK1-RPGR in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations

  NCT03316560· 1/2. fázis· Forrás

• Fut, nem toboroz

  Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration

  NCT02286089· 1/2. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Időskori makuladegeneráció5 toboroz
• Retinitis pigmentosa2 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  Next Generation Rocklatan

  NCT06441643· 2. fázis· Forrás

• Lezárult

  A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  NCT05811351· 2. fázis· Forrás

• Leállították

  HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

  NCT04566445· 2. fázis· Forrás

• Toboroz

  Hydrus® Microstent New Enrollment Post-Approval Study

  NCT04553523· Forrás

• Lezárult

  A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema

  NCT04527107· 2. fázis· Forrás

• Leállították

  EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

  NCT04437368· 2. fázis· Forrás

• Lezárult

  A Patient Registry Study for Patients Treated With Voretigene Neparvovec in US

  NCT03597399· Forrás

• Leállították

  GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)

  NCT03894020· Forrás

• Leállították

  FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD

  NCT03846193· 1/2. fázis· Forrás